Revenue: The sum of all revenue fields included for a company's operating activities.
Sonoma Pharmaceuticals, Inc. (SNOA) had Revenue of $3.14M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$3.14M |
$-0.87M |
|
$1.68M |
|
$1.46M |
|
$3.98M |
|
$-0.84M |
|
$-0.08M |
|
$-0.92M |
|
$-0.92M |
|
$-0.87M |
|
$-0.87M |
|
$-0.87M |
|
$-0.87M |
|
$-0.84M |
|
$-0.80M |
|
10.91M |
|
10.91M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$12.50M |
|
$0.40M |
|
$2.12M |
|
$14.62M |
|
$3.07M |
|
-- |
|
$4.85M |
|
$7.93M |
|
$6.69M |
|
$6.69M |
|
$6.69M |
|
13.68M |
|
| Cash Flow Statement Financials | |
$-2.55M |
|
$-0.02M |
|
$1.05M |
|
$3.82M |
|
$2.41M |
|
$-1.41M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.07 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
46.53% |
|
-26.90% |
|
-26.90% |
|
-- |
|
-29.41% |
|
-27.60% |
|
$-2.57M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.57 |
|
1.09 |
|
82.49 |
|
-12.94% |
|
-12.94% |
|
-5.92% |
|
-12.94% |
|
$0.49 |
|
$-0.24 |
|
$-0.23 |
|